Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

“Mesoridazine and Chlorpromazine in the Treatment of Alcohol Withdrawal Syndrome” *

The Canadian Journal of Psychiatry

Impact Factor: 4.4 / 5-Year Impact Factor: 4.4

Journal Homepage Submission guidelines

Free access

Letter

First published online February, 1974

“Mesoridazine and Chlorpromazine in the Treatment of Alcohol Withdrawal Syndrome” *

Volume 19, Issue 1

https://doi.org/10.1177/070674377401900135

Abstract

Browse journal

Current issue OnlineFirst All issues

Similar articles

Restricted access

The Adequacy of Commitment Evaluations Performed by Psychiatric and Non-psychiatric Physicians

Restricted access

MADD Massachusetts Versus Senator Burke: A Media Advocacy Case Study

Restricted access

Restricted access

Diclofenac Increases Beta-Endorphin Plasma Concentrations